Femtosecond laser image-guided high-precision trabeculotomy, or FLigHT, for primary open-angle glaucoma showed positive safety and efficacy results in a first-in-human study, according to a press release from ViaLase.
The 12-month prospective, nonrandomized study assessed the safety of FLigHT and its ability to lower IOP in a cohort of 15 eyes with open-angle glaucoma or ocular hypertension.
At 12 months, no treatment-related adverse events were reported, and there was a reduction in mean IOP. No eyes needed IOP-lowering medication.
In addition, on gonioscopy, there was no evidence of scarring